Neurocrine’s $2.9B Acquisition of Soleno: A Big Move into Rare Disease Market
In a major development in the global biotech sector, Neurocrine Biosciences has announced the acquisition of Soleno Therapeutics…
Eli Lilly Acquires Ventyx for $1.2B to Boost Oral Therapies
Indianapolis, USA: Pharmaceutical giant Eli Lilly & Co. has announced the acquisition of U.S.-based biotech company Ventyx Biosciences…


































































